Phase 3 randomised study of avatrombopag, a novel thrombopoietin receptor agonist for the treatment of chronic immune thrombocytopenia - Publication - Bridge of Knowledge

Search

Phase 3 randomised study of avatrombopag, a novel thrombopoietin receptor agonist for the treatment of chronic immune thrombocytopenia

Abstract

Citations

  • 1 3 9

    CrossRef

  • 0

    Web of Science

  • 1 4 6

    Scopus

Authors (7)

  • Photo of MD, PhD, Prof Wojciech Jurczak

    Wojciech Jurczak MD, PhD, Prof

  • Photo of  Krzysztof Chojnowski

    Krzysztof Chojnowski

  • Photo of  Jiří Mayer

    Jiří Mayer

  • Photo of  Katarzyna Krawczyk

    Katarzyna Krawczyk

  • Photo of  Brian Jamieson

    Brian Jamieson

  • Photo of  Wei Tian

    Wei Tian

  • Photo of  Lee Allen

    Lee Allen

Cite as

Full text

full text is not available in portal

Details

Category:
Magazine publication
Type:
Magazine publication
Published in:
BRITISH JOURNAL OF HAEMATOLOGY no. 183, edition 3, pages 479 - 490,
ISSN: 0007-1048
ISSN:
0007-1048
Publication year:
2018
DOI:
Digital Object Identifier (open in new tab) 10.1111/bjh.15573
Verified by:
No verification

seen 79 times

Meta Tags